Klaus Orlinger

Insider Reports History

Entity
Individual
Location
C/O Hookipa Pharma Inc., 350 Fifth Avenue, 72 Nd Floor, Suite 7240, New York, NY
Signature
/s/ Reinhard Kandera, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Klaus Orlinger:

Stock Role Class Num Shares Value Price $ Report Date Ownership
HOOKIPA Pharma Inc. Chief Scientific Officer Stock Option (Right to Buy) 367K Apr 15, 2024 Direct

Insider Reports Filed by Klaus Orlinger

Symbol Company Period Transactions Value $ Form Type Date Filed Role
HOOK HOOKIPA Pharma Inc. Apr 15, 2024 1 $0 4 Apr 17, 2024 Chief Scientific Officer
HOOK HOOKIPA Pharma Inc. Apr 14, 2023 1 $0 4 Apr 18, 2023 Chief Scientific Officer
HOOK HOOKIPA Pharma Inc. Jun 30, 2022 1 $0 4 Jul 1, 2022 Chief Scientific Officer
HOOK HOOKIPA Pharma Inc. Apr 19, 2022 1 $0 4 Apr 20, 2022 Chief Scientific Officer
HOOK HOOKIPA Pharma Inc. Feb 1, 2022 2 $65.5K 4 Feb 1, 2022 Executive VP, Research